Cambridge Catalog  
  • Your account
  • View basket
  • Help
Home > Catalog > Ethics and the Pharmaceutical Industry
Ethics and the Pharmaceutical Industry
Google Book Search

Search this book



  • Page extent: 528 pages
  • Size: 228 x 152 mm
  • Weight: 0.94 kg
Add to basket


 (ISBN-13: 9780521854962 | ISBN-10: 0521854962)

Manufactured on demand: supplied direct from the printer

$67.00 (P)

Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Debates are raging over how the industry can and should be expected to act. In this volume leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, marketing and advertising. . Michael Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry and China business strategy. As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines and Fair Credit Reporting Act. Thomas Gorrie is Corporate Vice President, Government Affairs & Policy, at Johnson & Johnson, with responsiblity for all federal, state and international government affairs and policy. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich, following the receipt of his doctorate at Princeton University. Gorrie has over 30 years of worldwide health care experience and has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international, venture capital, and health policy.


Charting a sustainable path for the 21st century pharmaceutical industry Michael A. Santoro; Part I. Profits, Patients' Rights, and Scientific Progress: The Ethics of Clinical Research Conducted in Private Enterprises: 1. Drug research: between ethical demands and economic constraints Jurgen Drews; 2. Emerging international norms for clinical testing: good clinical trial practice Juhana E. Idanpaan-Heikkila and Sev S. Fluss; 3. The regulatory and ethical challenges of pediatric research M. Dianne Murphy and Sara F. Goldkind; 4. Including children in research: participation or exploitation? Robert M. Nelson; 5. Racial and ethnic inclusiveness in clinical trials Valentine J. Burroughs; 6. The rights of patients to participate in clinical trials Glenna Crooks; 7. How should government regulate stem-cell research? Perspectives of a scientist-legislator The Hon. Rush Holt; Part II. Marketing and the Efficient Utilization of Healthcare Resources: Ethical and Public Policy Challenges: 8. Ethics and prescribing: the clinician's perspective Charles L. Bardes; 9. Direct-to-consumer advertising of prescription drugs: a policy dilemma Meredith B. Rosenthal and Julie M. Donohue; 10. Regulation of prescription drug promotion Thomas Abrams; 11. Off-label communications in marketing prescription drugs Scott D. Danzis; 12. The need for better health information: advancing the informed patient in Europe Don E. Detmer, Peter Singleton and Scott C. Ratzan; 13. Who should get access to which drugs? An ethical template for pharmacy benefits Norman Daniels, James E. Sabin and J. Russell Teagarden; 14. The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals Joel Hay; Part III. Patents, Pricing, and Equal Access: 15. Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities Patricia H. Werhane and Michael Gorman; 16. A future agenda for government-industry relations William Weldon; 17. AIDS activism and the pharmaceutical industry Martin Delaney; 18. The campaign against innovation Sidney Taurel; 19. Third world perspectives on global pharmaceutical access James Thuo Gathii; 20. The promise of vaccines and the influenza shortage of 2004: public and private partnerships Gary R. Noble; Part IV. Charting a Sustainable Path for the 21st Century: 21. Evolving approaches to healthcare challenges Thomas M. Gorrie; 22. Property rights in crisis: managers and rescue Nien-he Hsieh; 23. Blurring the lines: public and private partnerships addressing global health William Foege; 24. Renegotiating the grand bargain: balancing prices, profits, people, and principles Greg Koski.


"Santoro and Gorrieas book tackles one of the most controversial issues affecting our society 'healthcare: an economic commodity or basic human right?' At the heart of this debate is the role of the pharmaceutical industry. The book highlights effectively the opposing forces underlying the tension between the need for financial incentive for drug discovery and the global need for affordable medicines. It succeeds in providing provocative yet balanced perspectives from leaders of industry, government, ethics, business and healthcare. This book is a must read."
-Dr. Victor J. Dzau, President and Chief Executive Officer, Duke University Health System and Chancellor for Health Affairs, Duke University Medical Center

"For intelligent debate on the crisis of confidence in Big Pharma, this volume is unsurpassed. Santoro and Gorrie have assembled an impressive array of voices to tackle contentious issues plaguing the industry, from physician professionalism and research integrity to drug pricing, direct-to-consumer advertising, and intellectual property rights. Combining rigorous analysis with provocative proposals for change, this timely volume should be prescribed reading for industry leaders, policy-makers, and citizens alike."
-Lynn S. Paine, John G. McLean Professor of Business Administration, Harvard Business School

"This book provides thoughtful dialogue from diverse viewpoints on some of the most significant issues in health care -- we need this kind of meaningful dialogue to happen more often."
-Tommy G. Thompson, Former Secretary of Health and Human Services and Former Governor of Wisconsin

"Michael Santoro and Thomas Gorrie have compiled a series of essays that provide a fair, balanced, and insightful examination of an increasingly troubled relationship between the pharmaceutical industry and society."
-Henry Thomas Stelfox, Journal of the American Medical Association

"Ethics and the Pharmaceutical Industry is a timely and thoughtful addition to the growing literature on this controversial subject...I highly recommend this collection of essays as a beginning of a pathway for all parties involved in healthcare."
-Alan T. Kaell, Pharmacy and Therapeutics

"Suffice it to say the book has something in it for almost everyone interested in health care, ethics, and pharmaceuticals. You will learn something from some of the authors, while others will likely make you mad. But they all make you think."
-Merrill Matthews, Journal of the National Association for Business Economics

"Santoro and Gorrie have woven together a rich collection of perspectives in Ethics and the Pharmaceutical Industry, with contributors ranging from activists and academicians to regulators and representatives from the industry."
-Jeremy Sugarman, Johns Hopkins University, The New England Journal of Medicine

"Santoro, Gorrie and their contributors succeed in assembling a text that presents the key issues of business conduct for multinational pharmaceutical corporations, in a spirit of dialogue and respect for truly diverse perspectives."
-William Avery Hudson blog

"A timely and fair-minded overview of many drug-related issues."
-Future Survey


Thomas Abrams, Charles L. Bardes, Valentine J. Burroughs, Glenna Crooks, Norman Daniels, Scott D. Danzis, Martin Delaney, Don E. Detmer, Julie M. Donohue, Jurgen Drews, Sev Fluss, William Foege, Sara F. Goldkind, James Thuo Gathii, Michael Gorman, Thomas M. Gorrie, Joel Hay, The Hon. Rush Holt, Nien-he Hsieh, Juhana E. Indapaan-Heikkila, Greg Koski, M. Dianne Murphy, Robert M. Nelson, Gary R. Noble, Scott C. Ratzan, Meredith B. Rosenthal, James E. Sabin, Michael A. Santoro, Peter Singleton, J. Russell Teagarden, Sidney Taurel, Patricia H. Werhane, William Weldon

printer iconPrinter friendly version AddThis